Capital Flow Monitor · Sponsors · CIK 1650331
Summus Global, Inc.
10 East 40th Street, Suite 1910, NEW YORK, NY, 10018 · 917-565-8540
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$27.0M
Sold
$20.0M
% sold
74.0%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-07 | D ·current | 506(b) | $27.0M | $20.0M | 74.0% | 3 | EDGAR ↗ |
| 2025-08-06 | D | 506(b) | $12.0M | $7.5M | 62.5% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Julian Flannery — Executive Officer / Director, New York, NY
-
Aftab Kherani — Director, New York, NY
1 other raise
- Treeline Biosciences, Inc. $200.1M of $250.0M · 80.0%
- Arif Nathoo — Director, New York, NY
- Rick Buhrman — Director, New York, NY
- Kristi Henderson — Director, New York, NY
- Dennis Purcell — Executive Officer, New York, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.